| Patents for C07D 285 - Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups (9,964) |
|---|
| 04/13/2005 | EP1134222B1 IMIDAZO[4,5-b]PYRIDINIUMMETHYL-CONTAINING CEPHEM COMPOUNDS HAVING BROAD ANTIBACTERIAL SPECTRUM |
| 04/13/2005 | CN1606560A Novel benzothiazine and benzothiadiazine derivatives, method for preparing same, their use and pharmaceutical compositions containing same |
| 04/13/2005 | CN1606559A Novel benzothiazine and benzothiadiazine derivatives, method for preparing same, their use and pharmaceutical compositions containing same |
| 04/13/2005 | CN1606550A Benzothia(dia)zine derivatives and their use as AMPA modulators |
| 04/13/2005 | CN1196700C Aminoheterocyclylamides as pesticides and antiparasitic agents |
| 04/12/2005 | US6878743 Controlling apoptosis; central nervous system disorders |
| 04/12/2005 | US6878702 Anti-inflammatory agents |
| 04/07/2005 | WO2005030736A1 Derivatives of 1,3-diones having a herbicidal activity |
| 04/07/2005 | WO2005007636B1 1,2,4- thiadiazol-5-thio compounds and the derivatives thereof, methods for the production thereof and use thereof as urease and nitrification inhibitors |
| 04/07/2005 | US20050075330 Dipeptidyl peptidase inhibitors |
| 04/07/2005 | US20050075323 Beta3 adrenergic receptor agonists and uses thereof |
| 04/07/2005 | US20050074668 Perfluorinated amide salts and their uses as ionic conducting materials |
| 04/07/2005 | CA2539744A1 Derivatives of 1,3-diones having a herbicidal activity |
| 04/06/2005 | EP1519932A1 Bisarylsulfonamide compounds and their use in cancer therapy |
| 04/06/2005 | EP1519929A1 2,1,3-benzothiadiazoles for use as electronic active components |
| 04/06/2005 | CN1603964A Organophotoreceptor with charge transport material having bis(9-fluorenone) azine groups |
| 04/06/2005 | CN1195734C Phthalamide derivs., intermediates in production thereof, and agricultural/horticultural insecticides and method of using same |
| 04/05/2005 | US6875768 Phthalamide derivatives, intermediates in the production thereof, and agricultural/horticultural insecticides and method for using the same |
| 03/31/2005 | US20050070706 Antidiabetic agents; obesity; controlling appetite |
| 03/31/2005 | US20050070535 Antidiabetic agents; obesity; controlling appetite |
| 03/31/2005 | US20050070531 Using such as 2-[2-(3-Amino-piperidin-1-yl)4-oxo-4H-quinazolin-3-ylmethyl]-benzonitrile to treat cancer and/or autoimmune disorder |
| 03/31/2005 | US20050070530 Dipeptidyl peptidase inhibitors |
| 03/31/2005 | US20050069795 Organophotoreceptor with charge transport material having bis(9-fluorenone) azine groups |
| 03/31/2005 | US20050069794 Organophotoreceptor with charge transport material having fluorenone hydrazone groups |
| 03/30/2005 | EP1519240A2 Organophotoreceptor with charge transport material having bis(9-fluorenone) azine groups |
| 03/30/2005 | EP1519235A2 Linked dihydrazone-based charge transport compounds |
| 03/30/2005 | EP1517882A1 Amide linker peroxisome proliferator activated receptor modulators |
| 03/30/2005 | CN1602191A Compounds and uses thereof for decreasing activity of hormone-sensitive lipase |
| 03/29/2005 | US6872852 Polyamine analogues as cytotoxic agents |
| 03/29/2005 | US6872737 Drugs such as 4-Benzyl-2-methyl-1,2,4-thiadiazolidine-3,5 -dione inhibitors of glycogen synthase kinase-3 (GSK-3), for prophylaxis of neurodegenerative disorders, cancer, hyperplasia, psoriasis, arteriosclerosis or restinosis |
| 03/24/2005 | WO2005026139A1 Nematicidal difluoroalkenes |
| 03/24/2005 | WO2005025293A2 Fused ring heterocycles as potassium channel modulators |
| 03/24/2005 | US20050065148 Dipeptidyl peptidase inhibitors |
| 03/24/2005 | US20050065146 Cognition activators; neurodegenerative diseases; anxiolytic agents;psychological disorders; alzheimer's disease; Huntington's disease; antiischemic agents; antiepileptic agenst |
| 03/24/2005 | US20050065118 Compound containing 1,3,4-thiadiazole group; anticancer agents; autoimmune disease; antidiabetic agents |
| 03/24/2005 | US20050065095 Antibacterial agents |
| 03/24/2005 | DE10339568A1 3-Halogen-1,2,4-Thiadiazole 3-halogeno-1,2,4-thiadiazoles |
| 03/24/2005 | CA2788502A1 Non-peptide agonists and antagonists of adrenomedullin and gastric releasing peptide |
| 03/24/2005 | CA2536633A1 Fused ring heterocycles as potassium channel modulators |
| 03/23/2005 | EP1516875A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 03/23/2005 | EP1516874A1 Fungicidal heterocyclic aromatic amides and their compositions, methods of use and preparation |
| 03/23/2005 | EP1515956A1 Peptide deformylase inhibitors |
| 03/23/2005 | EP1515944A1 Aspartyl protease inhibitors |
| 03/23/2005 | EP1515726A1 Morpholine and tetrahydropyran derivatives and their use as cathepsin inhibitors |
| 03/23/2005 | EP1515709A2 Use of an alpha2delta ligand such as gabapentin or pregabalin for treating attention deficit hyperactivity disorder |
| 03/23/2005 | CN1598699A Linked dihydrazone-based charge transport compounds |
| 03/23/2005 | CN1597672A Substituierte benzoylcyclohexandione |
| 03/22/2005 | US6869454 Dyeing agents for keratin fibers, especially human hair |
| 03/22/2005 | CA2225250C Bicyclic amino derivatives and pgd2 antagonist containing the same |
| 03/17/2005 | WO2005023183A2 Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use |
| 03/17/2005 | WO2005023182A2 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 03/17/2005 | WO2004074270B1 Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same |
| 03/17/2005 | US20050059823 quinazolinone compounds such as 2-cyclopropyl-4-oxo-3-((p-fluorobenzyl)carbonylamino)-7-fluoro-1,2-dihydroquinazoline; brain and nervous system disorders such as mood disorders or neuropathic pain |
| 03/17/2005 | US20050059655 Nitrosated and nitrosylated diuretic compounds, compositions and methods of use |
| 03/17/2005 | US20050058916 Linked dihydrazone-based charge transport compounds |
| 03/17/2005 | CA2536975A1 Nitrosated and nitrosylated diuretic compounds, compositions and methods of use |
| 03/17/2005 | CA2536967A1 Nitrosated and nitrosylated cardiovascular compounds, compositions and methods of use |
| 03/16/2005 | EP1513802A1 Alpha-sulfonylamino-acetonitriles |
| 03/16/2005 | EP0758324B1 Substituted aromatic thiocarboxylic acid amides and their use as herbicides |
| 03/15/2005 | US6867243 Making by photopolymerization of a reactive mesogen having a photopolymerizable endgroup, such as a diene; intermediate 2,7-bis(5-(4-hydroxyphenyl)thien-2-yl)-9,9-dipropylfluorene |
| 03/10/2005 | WO2005021520A1 Substituted 1,2,4-thiadiazoles |
| 03/10/2005 | WO2005021490A2 N-SULFONYL-α-AMINO-ACID DERIVATIVES |
| 03/10/2005 | WO2005020991A1 Compounds for the treatment of neurodegenerative disorders |
| 03/10/2005 | WO2004103278A3 Acyl sulfonamides as inhibitors of hiv integrase |
| 03/10/2005 | US20050054819 Such as 1-benzylcyclobutyl (1S)-1-(oxo{[(1R)-1-phenylethyl]amino}acetyl)pentylcarbamate for treatment of osteoporosis |
| 03/09/2005 | EP1123918B1 Aromatic amine derivatives, process for the preparation thereof and agents containing the same |
| 03/03/2005 | WO2005019212A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 03/03/2005 | WO2005019192A1 Urea derivatives and their use as tyrosinkinase inhibitors |
| 03/03/2005 | WO2005019191A2 1, 1-dioxido-4h-1,2,4-benzothiadiazine derivate und verwandte verbindungen als inhibitoren der hcv polymerase zur behandlung von hepatitis c |
| 03/03/2005 | WO2005019184A1 Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide |
| 03/03/2005 | WO2005000309A3 Chemical compounds |
| 03/03/2005 | WO2005000298A3 5-membered heterocycle-based p-38 inhibitors |
| 03/02/2005 | EP1509497A1 Calcium receptor modulating arylalkylamines |
| 03/02/2005 | EP1509231A1 Peritoneal dialysis solution with taurolidine |
| 03/02/2005 | EP1042279B1 Substituted beta-alanines |
| 03/02/2005 | CN1589153A Preventives/remedies for urinary disturbance |
| 03/02/2005 | CN1191063C Antagonists for treatment of CD11/CD18 adhesion receptor mediated disorders |
| 03/01/2005 | US6861421 Nociceptin analogs |
| 03/01/2005 | US6861106 Dichroic dye, composition thereof, and liquid crystal composition and liquid crystal display element containing the same |
| 02/24/2005 | WO2005016911A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/24/2005 | WO2005016862A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | US20050043373 Tyrosine phosphatase inhibitor; antidiabetic agents; insulin resistance; obesity |
| 02/24/2005 | US20050043372 Compounds for the treatment of neurodegenerative disorders |
| 02/24/2005 | US20050043307 Novel heterocycle as agonist or antagonist for nervous systems which can contain double or triple bonds with nitrogen, oxygen or sulfur with carbon or azo groups and or salts and as modulators or receptors with carriers |
| 02/24/2005 | CA2535665A1 Substituted arylalkanoic acid derivative and use thereof |
| 02/24/2005 | CA2535619A1 4-pyrimidone derivatives and their use as peptidyl peptidase inhibitors |
| 02/23/2005 | EP1507529A1 Combination of organic compounds |
| 02/23/2005 | CN1585769A A2b adenosine receptor antagonists |
| 02/23/2005 | CN1585636A Use of endothelin receptor antagonists in the treatment of tumour diseases |
| 02/22/2005 | CA2162705C Magnesium salt of 3-isopropyl-2,1,3-benzothiadiazin-4-one 2,2-dioxide, its preparation and its use for controlling undesirable plant growth |
| 02/17/2005 | WO2005013914A2 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/17/2005 | WO2004002491A8 Morpholine and tetrahydropyran drivatives and their use as cathepsin inhibitors |
| 02/17/2005 | US20050038045 A2B adenosine receptor antagonists |
| 02/17/2005 | US20050038016 Arylamine-substituted quinazolinone compounds useful as alpha 1A/B adrenergic receptor antagonists |
| 02/17/2005 | US20050038009 1,1-dioxo-3,3-dibutyl-5-phenyl-7-methylthio-8-(N-{(R)- alpha -[N-((S)-1-carboxypropyl) carbamoyl]-4-hydroxybenzyl}carbamoylmethoxy)-2,3,4,5-tetrahydro-1,2,5-benzothiadiazepine |
| 02/17/2005 | DE10332288A1 1,2,4-Thiadiazol-5-thioverbindungen und deren Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Urease- und Nitrifikationsinhibitoren 1,2,4-thiadiazole-5-thio compounds and derivatives thereof, processes for their preparation and their use as urease and nitrification inhibitors |
| 02/17/2005 | CA2539227A1 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 02/16/2005 | EP1506967A1 Dipeptidyl peptidase inhibitors |
| 02/16/2005 | EP1505968A1 Multicyclic compounds for use as melanin concentrating hormone antagonists in the treatment of obesity and diabetes |
| 02/16/2005 | CN1582151A Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibitory activity for the treatment hyperlipidaemia |